As of Mar 31
| +0.13 / +2.90%|
The 4 analysts offering 12-month price forecasts for Synergy Pharmaceuticals Inc have a median target of 7.25, with a high estimate of 9.00 and a low estimate of 5.75. The median estimate represents a +56.93% increase from the last price of 4.62.
The current consensus among 4 polled investment analysts is to Buy stock in Synergy Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.